Nerve Growth Factor and Brain-Derived Neurotrophic Factor in Human Paediatric Hemimegalencephaly

Neuropediatrics

Volumn 35, Issue 1, 2004, Pages 39-44

  Antonelli, A ^a   Chiaretti, A ^b   Amendola, T ^a   Piastra, M ^b   Di Rocco, C ^c   Aloe, L ^a  

^a CNR   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

BDNF; Choline acetyltransferase; Hemimegalencephaly; NGF; NGF receptors

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CHOLINE ACETYLTRANSFERASE; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR;

ALEXANDER DISEASE; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; CLINICAL FEATURE; FEMALE; HEMIMEGALENCEPHALY; HEMISPHERE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MENTAL DEFICIENCY; NEUROPATHOLOGY; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEIZURE; SYMPTOM; THICKNESS;

ANTIBODIES; BRAIN; BRAIN DISEASES; BRAIN-DERIVED NEUROTROPHIC FACTOR; CARRIER PROTEINS; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNCTIONAL LATERALITY; HUMANS; INFANT; MALE; MEMBRANE PROTEINS; NERVE GROWTH FACTOR; RECEPTOR, TRKA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 1542619410     PISSN: 0174304X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-815790     Document Type: Article

References (37)

1. Alderson RF, Alterman AL, Barde YA, Lindsay RM. Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture. Neuron 1990; 5: 297-306
2. Aloe L, Bracci-Laudiero L, Bonini S, Manni L. The expanding role of nerve growth factor: from neurotrophic activity to immunologic diseases. Allergy 1997; 52: 883-994
3. Anand P, Terenghi G, Warner G, Kopelman P, Williams-Chestnut RE. The role of endogenous nerve growth factor in human diabetic neuropathy. Nature Med 1996; 2: 703-707
4. Auld DS, Mennicken F, Day JC, Quirion R. Neurotrophins differentially enhance acetylcholine release, acetylcholine content and choline acetyltransferase activity in basal forebrain neurons. J Neurochem 2001; 77: 253-262
5. Bernabei R, Landi F, Bonini S, Onder G, Lambiase A, Pola R, Aloe L. Tropical application of nerve growth factor accelerates healing of pressure ulcer in humans. Lancet 1999; 354: 182-185
6. Bosman C, Boldrini R, Dimitri L, Di Rocco C, Corsi A. Hemimegalencephaly. Histological, immunohistochemical, ultrastructural and cytofluorimetric study of six patients. Child's Nerv System 1996; 12: 765-775
7. Bowes M, Tuszynski MH, Conner J, Zivin JA. Continuous intrathecal fluid infusion elevate Nerve Growth factor levels and prevent functional deficits after spinal cord ischemia. Brain Res 2000; 883: 178-183
8. Cimino M, Cattabeni F, Di Luca M, Peruzzi G, Andena M, Tirassa P, Angelucci F, Cozzari C, Aloe L. Levels of NGF, P75 NGFR and Chat immunoreactivity in brain of adult and aged microencephalic rats. Neurobiol Aging 1996; 7: 146-149
9. Chen EY, Mufson EJ, Kordower JH. TRK and P75 neurotrophin receptor system in the developing human brain. J Comp Neurol 1996; 369: 591-618
10. Clancy RR, Kurtz MB, Baker D, Sladky JT, Honig PJ, Younkin DP. Neurological manifestations of the organoid nevus syndrome. Arch Neurol 1985; 42: 236-240
11. Connor B, Dragunow M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Rev 1998; 27: 1-39
12. Dambska M, Wisniewski K, Sheik J. An autopsy case of hemimegalencephaly. Brain Dev 1984; 6: 60-64
13. De Rosa MJ, Secor DL, Barsom M, Fisher RS, Vinters HV. Neuropathologic findings in surgically treated hemimegalencephaly. Acta Neuropathol 1992; 84: 250-260
14. Dixon CE. Nerve growth factor attenuates cholinergic deficits following traumatic brain injury in rats. Experimental Neurol 1997; 146: 479
15. Dobyns WB, Reiner O, Carrozzo R, Ledbetter DH. A human brain malformation associated with delection of L1S1 gene located at chromosome 17 p13. JAMA 1993; 270: 2838-2842
16. Greene LA, Tischler AS. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 1976; 73: 2424-2428
17. Hirashima Y, Endo S, Karasawa K, Sato N, Yokoyama K, Kurimoto M, Ikeda H, Setaka M, Takaku A. Deficient platelet-activating factor and related enzymes in hemimegalencephaly. Child's Nerv System 1999; 15: 98-102
18. Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, Squinto SP, Lindsay RM. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 1991; 350: 230-232
19. Kato M, Mizuguchi M, Sakuta R. Hypertrophy of the cerebral white matter in hemimegalencephaly. Pediatr Neurol 1996; 14: 335-338
20. Korhonen L, Raili R, Hiroyuki N, Lidholm D. Brain derived neurotrophic factor is increased in cerebrospinal fluid of children suffering from asphyxia. Neuroscience Letters 1998; 240: 151-154
21. Lambiase A, Rama P, Bonini St, Caprioglio G, Aloe L. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med 1998; 338: 1174-1180
22. Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987; 237: 1154-1162
23. Mamounas LA, Blue ME, Siuciak JA. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J Neurosci 1995; 15: 7929-7939
24. Meakin SO, Shooter EM. The nerve growth factor family of receptors. Trends Neurosci 1992; 15: 323-331
25. Molnar M, Tongiorgi E, Avignone E, Gonfloni S, Ruberti F, Domenici L, Cattaneo A. The effects of anti-nerve growth factor monoclonal antibodies on developing basal forebrain neurons are transient and reversible. Eur J Neurosci 1998; 10: 3127-3140
26. Nakahashi T, Fujimura H, Altar CA, Li J, Kambayashi J, Tandon NN, Sun B. Vascular endothelial cells synthetise and secrete brain-derived neurotrophic factor. FEBS Lett 2000; 470: 113-117
27. Shimohama S, Tamura Y, Akaike A, Tsukahara T, Iwata H, Kimura J. Brain-derived neurotrophic factor pretreatment exerts a partially protective effect against glutamate-induced neurotoxicity in cultured rat cortical neurons. Neurosci Lett 1993; 164: 55-58
28. Siegel GJ, Chauhan NB. Neurotrophic factors in Alzheimer's and Parkinson's disease brain. Brain Res Rev 2000; 33: 199-227
29. Snider WD, Johnson Jr EM. Neurotrophic molecules. Ann Neurol 1989; 26: 489-506
30. Sofroniew MV, Howe CL, Mobley W. Nerve growth factor signalling, neuroprotection, and neural repair. Ann Rev Neurosci 2001; 24: 1217-1281
31. Spenger C, Hyman C, Studer L, Egli M, Evtouchenko L, Jackson C, Dahl-Jorgensen A, Linsday RM, Seiler RW. Effects of BDNF on dopaminergic, serotonergic, and GABAergic neurons in cultures of human fetal ventral mesencephalon. Exp Neurol 1995; 133: 50-63
32. Tirassa P, Manni L, Stenfors C, Aloe L. RT-PCR ELISA method for the analysis of neurotrophin mRNA expression in brain and peripheral tissues. J Biotechnol 2000; 84: 259-272
33. Tuveri M, Generine S, Matucci-Cenerini M, Aloe L. Nerve growth factor, an useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis. Lancet 2000; 356: 1739-1740
34. Vanhala R, Korhonen L, Mikelsaar M, Lindholm D, Riikonen R. Neurotrophic factors in cerebrospinal fluid and serum of patients with Rett syndrome. J Child Neurol 1998; 13: 429-433
35. Ventimiglia R, Mather PE, Jones BE, Linsday RM. The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro. Eur J Neurosci 1995; 7: 213-222
36. Villoslada P, Hauser SL, Bartke I, Unger J, Heald N, Rosemberg D, Cheung SW, Mobley WC, Fisher S, Genain CP. Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system. J Exp Med 2000; 191: 1799-1806
37. Weskamp G, Otten U. An enzyme-linked immunoassay for nerve growth factor (NGF): a tool for studying regulatory mechanisms involved in NGF production in brain and peripheral tissues. J Neurochem 1987; 48: 1779-1786